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Background
RCTs are considered the most rigorous design to evaluate
the effectiveness of different interventions but have gener-
alizability issues. Our tool, PRECIS, could help trialists
consider the effects of their design decisions on the applic-
ability of their results in clinical settings.
Aim
To produce an improved and validated version of
PRECIS.
Methods
Phase 1 involved brainstorming and a two-round Delphi
survey of authors who cited PRECIS. Phase 2 involved
discussion of the Delphi results by experienced trialists
and alternative versions of PRECIS-2 developed and
user-tested. Phase 3 will evaluate the validity and relia-
bility of the most promising PRECIS-2 candidate using a
sample of 15-20 trials rated by 15 other trialists.
Results
Brainstorming sessions identified the PRECIS presenta-
tion (a wheel), lack of a scoring system and domain
weighting as issues for exploration in the Delphi process.
Thirty four completed responses from 90 invitees were
received in Round 1 of the Delphi; Round 2 involved 23
individuals (response rate 82%). 45% selected a 1-5 Likert
scale, 56.5% wanted to use a table (to justify decisions)
and a PRECIS wheel, 26% were in favour of weighting
domains. Suggestions for extra domains included:
recruitment process for participants and integration of
the intervention into the healthcare system. An expert
panel in Toronto used the Delphi suggestions to help
create alternative versions of PRECIS-2 for user-testing
in spring 2013.
Conclusions
PRECIS can be improved by the addition of a Likert
scale and additional domains. We expect to have a vali-
dated PRECIS-2 by the beginning of 2014.
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